FDA NDC Directory · JSON-LD · Markdown

Doxorubicin Hydrochloride

NDC 68001-345 · HUMAN PRESCRIPTION DRUG · INJECTABLE, LIPOSOMAL

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA208657
Dosage form / routeINJECTABLE, LIPOSOMAL · INTRAVENOUS
Active ingredientsDOXORUBICIN HYDROCHLORIDE (2 mg/mL)
Marketing started20180216
Package count2

External sources

Source: openFDA. Public-domain (CC0).